non-op item slight core miss
lighter revenu good organ growth
report adj ep beat expect
report adjust ep ep beat consensus/in-lin
us primarili higher non-op incom core result light
top-lin result increas less expect y/i organ still led
growth segment mt cs ms core expens came higher
rate came higher off-set higher non-op incom compani
increas lower end expens guidanc given healthi top line growth
howev expens rang still in-lin
model manag pursu buyback quarter lower share
count paid debt lower leverag ratio though
remain elev overal mix quarter transit period despit healthi
competit valuat reiter neutral rate furthermor rais
po base higher organ growth outlook
posit quarter
inform servic rev y/i q/q aid evest acquisit
market servic rev less transact relat expens y/i q/q
list rev y/i flat q/q
corpor solut rev y/i q/q
market technolog rev y/i q/q
repurchas share qtr vs last qtr w/ remain
issu quarter
rais low end expens guidanc
recur expens y/i q/q partial due evest higher comp
margin fell bp y/i bp q/q
compani elev net debt level lower q/q
tax ex one-tim charg came expect vs
estim price object rate remain unchang compani due
hold confer call
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
pr pr solut digit media
invest
nasdaq omx group found
lead diversifi global exchang offer
trade clear servic market data
product technolog product servic
financi index product list servic public
compani servic compani own
oper market clearinghous
central secur depositori across
europ list compani
global grown year
organ via acquisit
given improv organ growth outlook
came sooner expect yet limit margin
expans elev leverag potenti
area regulatori chang believ
share trade in-lin group
price object po base target pe multipl
ep premium recent histor averag given increas
portion recur revenu deriv po consid three primari factor
exchang revenu mix growth expect competition/barri
entri price manag abil manag margin cash flow well
strategi also look regulatori environ macro backdrop earn
volatil risk factor believ share trade in-lin
group given improv organ growth outlook yet limit margin expans
elev leverag expect hit leverag target till potenti
area regulatori chang
upsid risk po weak macro backdrop reduc competit less price
pressur margin technolog oper accret regulatori legal
downsid risk po lower volum outlook higher price pressur lower non-
transact revenu lower margin failur opportun
michael carrier cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
new york mellon
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
